|
2025
|
P/S
|
Pharmaceutical preparations and substances; atypical antipsychotics; medications indicated for th... |
|
|
Invention
|
Topical compositions.
The disclosure provides a topical gel formulation comprising 1-1.5 wt. % c... |
|
|
P/S
|
Pharmaceutical preparations and substances; pharmaceutical preparations for the prevention and tr... |
|
|
P/S
|
Pharmaceutical preparations and substances; pharmaceutical
preparations for the prevention and t... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular disease; Cardiovascular pharmaceu... |
|
|
P/S
|
Pharmaceutical preparations and substances; Medicine. |
|
|
P/S
|
Pharmaceutical preparations and substances; Medicine; Dietetic products for medical purposes. |
|
|
P/S
|
Pharmaceutical products; medicines. |
|
|
P/S
|
Pharmaceutical substances and preparations to treat pain and
inflammation of the mouth and throat. |
|
|
P/S
|
Pharmaceutical preparations used in functional disorders of gastrointestinal tract; analgesic, an... |
|
|
P/S
|
pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical prepara... |
|
2024
|
P/S
|
Pharmaceutical preparations and substances. |
|
|
Invention
|
Methods for preventing, treating, or ameliorating ulcerative colitis in certain patient populatio... |
|
|
P/S
|
Pharmaceutical preparations and substances; antidiabetic drugs. |
|
|
Invention
|
Ultra-pure agonists of guanylate cyclase c, method of making and using same.
The invention provi... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
cardiovascular disease; cardiovascular pharmace... |
|
|
P/S
|
Pharmaceutical substances and preparations to treat pain and
inflammation of the mouth and throa... |
|
|
Invention
|
Topical compositions and methods for treating skin diseases.
Topical pharmaceutical compositions... |
|
|
P/S
|
Pharmaceutical preparations and substances; pharmaceutical products used in diseases of the gastr... |
|
|
Invention
|
Topical compositions. The disclosure provides a topical gel formulation comprising 1-1.5 wt. % cl... |
|
|
Invention
|
Topical compositions. The disclosure provides a formulation and method for treating dermatologica... |
|
|
Invention
|
Formulations of guanylate cyclse c agonists and methods of use.
The invention provides low-dose ... |
|
2023
|
Invention
|
Use of a fixed combination of halobetasol propionate and tazarotene to treat conditions mediated ... |
|
|
Invention
|
Ultra-pure agonists of guanylate cyclase c, method of making and using same. The invention provid... |
|
|
Invention
|
Methods for treating acne and skin oiliness with tazarotene. Methods are provided for treating ac... |
|
|
Invention
|
Topical compositions and methods for treating psoriasis.
Topical pharmaceutical compositions com... |
|
|
Invention
|
Anti-infective methods, compositions, and devices.
The present invention provides methods for tr... |
|
|
Invention
|
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammatio... |
|
|
Invention
|
Pharmaceutical formulations containing corticosteroids for topical administration.
Pharmaceutica... |
|
2022
|
Invention
|
Pharmaceutical formulations containing corticosteroids for topical administration. Pharmaceutical... |
|
|
Invention
|
Topical compositions and methods for treating psoriasis. Topical pharmaceutical compositions comp... |
|
|
Invention
|
Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspens... |
|
|
Invention
|
Methods of reducing mortality in subjects suffering from an underlying disease or condition by ad... |
|
|
Invention
|
Topical compositions comprising a macrolide immunosuppressant.
The disclosure provides topical p... |
|
|
Invention
|
Polymeric emulsion delivery systems.
Provided herein are compositions comprising an oil-in-water... |
|
|
Invention
|
Topical compositions and methods for treating skin diseases. Topical pharmaceutical compositions ... |
|
|
Invention
|
Topical pharmaceutical compositions for treating skin conditions.
Topical pharmaceutical composi... |
|
|
Invention
|
Methods of using rifamycin sv for the treatment of sickle cell disease.
Provided herein is the u... |
|
|
Invention
|
Amiselimod for preventing, treating or ameliorating ulcerative colitis.
Described herein are met... |
|
|
Invention
|
Amiselimod for preventing, treating, or ameliorating ulcerative colitis. Described herein are met... |
|
2021
|
Invention
|
Compositions and methods for treating diseases of the nail. Methods and compositions for treating... |
|
|
Invention
|
Use of methylnaltrexone and rifaximin for treatment of increased gut permeability or associated d... |
|
|
Invention
|
Rifaximin liquid formulations for use inthe treatment of sickle cell disease.
Pharmaceutical com... |
|
|
Invention
|
Rifaximin liquid formulations for use in the treatment of sickle cell disease. Pharmaceutical com... |
|
|
Invention
|
Liquid oral dosage formulations of methylnaltrexone.
Provided herein are pharmaceutical composit... |
|
|
Invention
|
Targeted release rifaximin compositions.
Provided herein are GI specific rifaximin release compo... |
|
|
Invention
|
Targeted release rifaximin compositions. Provided herein are GI specific rifaximin release compos... |
|
|
Invention
|
Methods of reducing mortality risk in subjects suffering from an underlying disease or condition ... |
|
|
Invention
|
Methods of using solid dispersions of rifaximin for the treatment of sickle cell disease.
Provid... |
|
|
Invention
|
Methods of using solid dispersions of rifaximin for the treatment of sickle cell disease. Provide... |
|
|
Invention
|
Methods of treating covid-19 with rifaximin.
Provided herein are methods for treating COVID-19 o... |
|
|
Invention
|
Solid dispersions of rifaximin for the treatment of overt hepatic encephalopathy.
Provided herei... |
|
|
Invention
|
Methods of treating covid-19 with rifaximin. Provided herein are methods for treating COVID-19 or... |
|
|
Invention
|
Solid dispersions of rifaximin for the treatment of overt hepatic encephalopathy. Provided herein... |
|
|
Invention
|
Agonists of guanylate cyclase and their uses.
This invention provides a method of colonic cleans... |
|
2020
|
Invention
|
Rifaximin liquid formulations.
Provided herein are pharmaceutical compositions which enhance the... |
|
|
Invention
|
Methods of treating nonalcoholic fatty liver disease (nafld) using il-17ra antibody.
The present... |
